Don't be too quick to scoff at the headline. This is not a denial of the tens of thousands of clinical studies that have been done, rather in fact a recognition of cannabis as a widespread medical modality which is starting to come of age in mainstream society.
The research is going to be extensive and promises to provide a very useful database that will help medical professionals and patients understand and be more precise going forward about which aspects of cannabis therapeutics depend on which variables in the medicine.
It's also being done in Canada so a lot of the usual US suspects, e.g., the DEA, FDA, and mossback prohibitionist politicians can't foul it up.
It’s being called the first real-world study of medical cannabis, and researchers at Toronto’s University Health Network (UHN) predict that it will provide much-needed insight into the link between cannabis genetics and patient outcomes. Led by Dr. Hance Clarke, director of pain services at Toro…